DMA110: Demystifying Market Access in the South African Healthcare Environment

Developed and authored by Mark Brand

Course Summary

This course is intended to assist those in the MedTech space considering introducing new technologies into South Africa. Medical device registration, e.g., FDA Certificates and CE Mark, are critical quality, safety and efficacy indicators, but are merely authorizations to enter a particular market. This represents an absolute minimum requirement for market access but are not a guarantee for adoption and/or reimbursement; policy makers/funders demand more!

Introducing new technologies to the South African Healthcare market may seem a daunting task, given the requirements of various relevant stakeholders as they manage prioritisation, utilization, and health care costs, through the use of tools such as Health Technology Assessment.

Although it has a market access focus, this workshop it not exclusively for market access personnel, and every level of business decision-maker will benefit by attending, and in so doing learn to navigate these hurdles efficiently within resource constrained businesses.

Why should you attend?

  • Understand macro environment issues
  • Successfully navigate complex market access processes
  • Engage and manage important stakeholders strategically
  • Introduction to health technology assessment - HTA
  • Enhance your applications for reimbursement
  • Understanding value and develop a value proposition
  • Align business and market access strategies
  • Integrate market access function into your portfolio

Who should attend?

Any medical device company representative who is involved in introducing new health technologies to the market, including (but not limited to):

  • Chief Executives,
  • Managing Directors,
  • Business Unit Managers,
  • Product Managers,
  • Marketing Managers and
  • Market Access Managers.

Shelley McGee

Insight Actuaries

Mark is an organised, knowledgeable and helpful course lecturer. My background is primarily in pharmaceuticals, and I learned a lot about HTA and processes for navigating reimbursement for other technologies on this course.

Lila Jacobs

Bayer

It was very well coordinated. Thanks Janine, for organizing everything and also your time.

Leigh Scholtz

Coloplast

A well-constructed programme offering an understanding of the complex Market Access landscape, its impact and its role in successful business outcomes. This course is well-paced and online, allowing flexibility to suit busy schedules. An expert in the field presents it, and personal engagement provides an opportunity for clarification as necessary.

Programme

  • Information session: 2 March 2023 - click to view recording

    Where and how HTA can support patient access to innovation

    Inviting all Medical Technology colleagues wishing to gain perspective on:

    • Importance of using HTA for medical devices
    • How HTA can promote patient access to innovative medical devices
    • What role can industry play in expediting HTA decision making
  • Study Unit 1: Navigating the South African Healthcare Environment

    Provide:

    • Background to the SA Health Care industry.
    • Useful industry demographic and economic indicators.
    • Industry structure and relationships between stakeholders.
    • Industry dynamics that are worth watching.
    • Macro environmental factors that may influence your market.
    • The ability to navigate market access hurdles and processes.

    Contact session: 28 Aug 2025

  • Study Unit 2: Health Technology Assessment (HTA)

    Provide:

    • A framework for Health Technology Management (HTM) and managing the technology lifecycle
    • How HTA offers a strategic approach to introducing new heath technologies.
    • How HTA fits into the health technology regulatory framework of South Africa.
    • A non-linear approach to managing introduction of health technologies.
    • Insight into the 3 distinct components of HTM, pre HTA, HTA and post HTA and unpacking these in the context of your business.

    Contact session: 4 Sept 2025

  • Study Unit 3: Developing a Market Access Strategy

    Provide:

    • Efficiently align business and reimbursement strategies
    • A systematic approach to developing a market access strategy aligned with the company’s business strategy.
    • An understanding of who the various stakeholders are in the decision-making process, their respective influence on each other and on your market access strategy.
    • A framework for defining a meaningful value proposition to each relevant stakeholder.
    • A guide on collating the information and creating the “dossier” for submission.

    Contact session: 11 Sept 2025

  • 25 Aug–26 Sep

    3 weeks duration

  • Certificate

    of completion awarded

  • 15 hours

    Study time

  • Fees (excl VAT)

    R4400 Corp Members
    R4675 Stand Members
    R4950 Ind Members
    R5500 Non Members

  • 3 live sessions

    with Mark Brand via Zoom - 19h00-21h00

Meet the Course Developer and Author

Mark Brand

Mark Brand

Independent HTA Consultant; MBA; Electrical Engineering; HTA (USB)

Click on image for bio

Scheduled Events

Please note that dates, topics and presenters are subject to change.

Latest Newsletter

Find us on